Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic</title><author><name sortKey="Lehnert, Jonathan D" sort="Lehnert, Jonathan D" uniqKey="Lehnert J" first="Jonathan D." last="Lehnert">Jonathan D. Lehnert</name><affiliation><nlm:aff id="af0001"><institution>IHRC, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Shevach, Alex" sort="Shevach, Alex" uniqKey="Shevach A" first="Alex" last="Shevach">Alex Shevach</name><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0003"><institution>Carter Consulting, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Walker, Sydney" sort="Walker, Sydney" uniqKey="Walker S" first="Sydney" last="Walker">Sydney Walker</name><affiliation><nlm:aff id="af0004"><institution>Northrop Grumman Corporation</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0005"><institution>Office of Health Communications Science, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Wang, Rose" sort="Wang, Rose" uniqKey="Wang R" first="Rose" last="Wang">Rose Wang</name><affiliation><nlm:aff id="af0005"><institution>Office of Health Communications Science, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Fitzgerald, Thomas J" sort="Fitzgerald, Thomas J" uniqKey="Fitzgerald T" first="Thomas J." last="Fitzgerald">Thomas J. Fitzgerald</name><affiliation><nlm:aff id="af0001"><institution>IHRC, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B." last="Graitcer">Samuel B. Graitcer</name><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">29451833</idno><idno type="pmc">6067886</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067886</idno><idno type="RBID">PMC:6067886</idno><idno type="doi">10.1080/21645515.2018.1440162</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000699</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000699</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic</title><author><name sortKey="Lehnert, Jonathan D" sort="Lehnert, Jonathan D" uniqKey="Lehnert J" first="Jonathan D." last="Lehnert">Jonathan D. Lehnert</name><affiliation><nlm:aff id="af0001"><institution>IHRC, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Shevach, Alex" sort="Shevach, Alex" uniqKey="Shevach A" first="Alex" last="Shevach">Alex Shevach</name><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0003"><institution>Carter Consulting, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Walker, Sydney" sort="Walker, Sydney" uniqKey="Walker S" first="Sydney" last="Walker">Sydney Walker</name><affiliation><nlm:aff id="af0004"><institution>Northrop Grumman Corporation</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0005"><institution>Office of Health Communications Science, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Wang, Rose" sort="Wang, Rose" uniqKey="Wang R" first="Rose" last="Wang">Rose Wang</name><affiliation><nlm:aff id="af0005"><institution>Office of Health Communications Science, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Fitzgerald, Thomas J" sort="Fitzgerald, Thomas J" uniqKey="Fitzgerald T" first="Thomas J." last="Fitzgerald">Thomas J. Fitzgerald</name><affiliation><nlm:aff id="af0001"><institution>IHRC, Inc.</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author><author><name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B." last="Graitcer">Samuel B. Graitcer</name><affiliation><nlm:aff id="af0002"><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></nlm:aff></affiliation></author></analytic><series><title level="j">Human Vaccines & Immunotherapeutics</title><idno type="ISSN">2164-5515</idno><idno type="eISSN">2164-554X</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>ABSTRACT</title><p>In an influenza pandemic, two vaccine doses administered 21 days apart may be needed for individuals of all ages to achieve seroprotection. Achieving dose-series completion can be challenging even for routinely recommended vaccines. To prepare for a two-dose influenza pandemic vaccine campaign and promote dose-series completion and correct dosing intervals, CDC and its partners developed a text message-based vaccine reminder system to remind persons who receive a first dose of pandemic influenza vaccine to receive the second dose. Taking advantage of the high prevalence of cell phones in the United States, the system sent second-dose text message reminders and hyperlinks to educational information. The system was pilot tested from November 2015 to April 2016 among graduate public health students enrolled at four United States universities. Universities were selected based on convenience, and each university used a different recruitment method. Among 59 volunteers who pilot tested the system and completed a survey, 57 (92%) felt the system would be helpful during a pandemic. Forty (68%) respondents felt the information included in the messages was informative. Volunteers recommended including actionable ways to stay healthy during a pandemic, though specific suggestions varied. With further development, text reminder systems could be used to promote adherence to a two-dose regimen in a future pandemic, although audience-specific messaging and other complementary systems will likely be needed. Public and private partners can adapt and implement this tool in conjunction with their routine patient information systems to improve dose-series completion and ensure optimal protection during an influenza pandemic.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Vaccin Immunother</journal-id><journal-id journal-id-type="iso-abbrev">Hum Vaccin Immunother</journal-id><journal-id journal-id-type="publisher-id">KHVI</journal-id><journal-id journal-id-type="publisher-id">khvi20</journal-id><journal-title-group><journal-title>Human Vaccines & Immunotherapeutics</journal-title></journal-title-group><issn pub-type="ppub">2164-5515</issn><issn pub-type="epub">2164-554X</issn><publisher><publisher-name>Taylor & Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29451833</article-id><article-id pub-id-type="pmc">6067886</article-id><article-id pub-id-type="publisher-id">1440162</article-id><article-id pub-id-type="doi">10.1080/21645515.2018.1440162</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic</article-title><alt-title alt-title-type="running-authors">J. D. LEHNERT ET AL.</alt-title><alt-title alt-title-type="running-title">HUMAN VACCINES & IMMUNOTHERAPEUTICS</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="ORCID">0000-0002-6795-930X</contrib-id><name><surname>Lehnert</surname><given-names>Jonathan D.</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="corresp" rid="an0001"></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shevach</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="af0002"><sup>b</sup></xref><xref ref-type="aff" rid="af0003"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Walker</surname><given-names>Sydney</given-names></name><xref ref-type="aff" rid="af0004"><sup>d</sup></xref><xref ref-type="aff" rid="af0005"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Rose</given-names></name><xref ref-type="aff" rid="af0005"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fitzgerald</surname><given-names>Thomas J.</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref><xref ref-type="aff" rid="af0002"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Graitcer</surname><given-names>Samuel B.</given-names></name><xref ref-type="aff" rid="af0002"><sup>b</sup></xref></contrib><aff id="af0001"><label>a</label><institution>IHRC, Inc.</institution>, Atlanta, GA,<country>USA</country></aff><aff id="af0002"><label>b</label><institution>Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></aff><aff id="af0003"><label>c</label><institution>Carter Consulting, Inc.</institution>, Atlanta, GA,<country>USA</country></aff><aff id="af0004"><label>d</label><institution>Northrop Grumman Corporation</institution>, Atlanta, GA,<country>USA</country></aff><aff id="af0005"><label>e</label><institution>Office of Health Communications Science, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention</institution>, Atlanta, GA,<country>USA</country></aff></contrib-group><author-notes><corresp id="an0001"><bold>CONTACT</bold> Jonathan D. Lehnert <email xlink:href="JLehnert@cdc.gov">JLehnert@cdc.gov</email><addr-line>1600 Clifton Road, MSA19</addr-line>, Atlanta, GA 30333</corresp></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>9</day><month>4</month><year>2018</year></pub-date><volume>14</volume><issue>7</issue><fpage seq="15">1647</fpage><lpage>1653</lpage><history><date date-type="received"><day>13</day><month>11</month><year>2017</year></date><date date-type="rev-recd"><day>11</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>9</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>© 2018 Taylor & Francis</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Taylor & Francis</copyright-holder></permissions><self-uri content-type="pdf" xlink:href="khvi-14-07-1440162.pdf"></self-uri><abstract><title>ABSTRACT</title><p>In an influenza pandemic, two vaccine doses administered 21 days apart may be needed for individuals of all ages to achieve seroprotection. Achieving dose-series completion can be challenging even for routinely recommended vaccines. To prepare for a two-dose influenza pandemic vaccine campaign and promote dose-series completion and correct dosing intervals, CDC and its partners developed a text message-based vaccine reminder system to remind persons who receive a first dose of pandemic influenza vaccine to receive the second dose. Taking advantage of the high prevalence of cell phones in the United States, the system sent second-dose text message reminders and hyperlinks to educational information. The system was pilot tested from November 2015 to April 2016 among graduate public health students enrolled at four United States universities. Universities were selected based on convenience, and each university used a different recruitment method. Among 59 volunteers who pilot tested the system and completed a survey, 57 (92%) felt the system would be helpful during a pandemic. Forty (68%) respondents felt the information included in the messages was informative. Volunteers recommended including actionable ways to stay healthy during a pandemic, though specific suggestions varied. With further development, text reminder systems could be used to promote adherence to a two-dose regimen in a future pandemic, although audience-specific messaging and other complementary systems will likely be needed. Public and private partners can adapt and implement this tool in conjunction with their routine patient information systems to improve dose-series completion and ensure optimal protection during an influenza pandemic.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>pandemic influenza</kwd><kwd>pandemic vaccination</kwd><kwd>public health preparedness</kwd><kwd>reminder-recall system</kwd></kwd-group><counts><fig-count count="2"></fig-count><table-count count="2"></table-count><equation-count count="0"></equation-count><ref-count count="22"></ref-count><page-count count="7"></page-count></counts></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0006990 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0006990 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.34. |  |